CN1733242A - Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same - Google Patents
Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same Download PDFInfo
- Publication number
- CN1733242A CN1733242A CN 200510097971 CN200510097971A CN1733242A CN 1733242 A CN1733242 A CN 1733242A CN 200510097971 CN200510097971 CN 200510097971 CN 200510097971 A CN200510097971 A CN 200510097971A CN 1733242 A CN1733242 A CN 1733242A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- heart disease
- coronary heart
- thoracic obstruction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 41
- 230000007812 deficiency Effects 0.000 title claims abstract description 15
- 210000000115 thoracic cavity Anatomy 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title abstract description 7
- 229940079593 drug Drugs 0.000 title description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 21
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 21
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000008280 blood Substances 0.000 claims description 39
- 210000004369 blood Anatomy 0.000 claims description 38
- 241000208340 Araliaceae Species 0.000 claims description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 19
- 235000008434 ginseng Nutrition 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 14
- 241000736148 Styrax Species 0.000 claims description 13
- 239000004870 Styrax Substances 0.000 claims description 13
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 6
- 241000411851 herbal medicine Species 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000009495 sugar coating Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000893513 Liquidambar orientalis Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000001886 liquidambar orientalis Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 14
- 206010002383 Angina Pectoris Diseases 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 206010002660 Anoxia Diseases 0.000 description 6
- 241000976983 Anoxia Species 0.000 description 6
- 206010021143 Hypoxia Diseases 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 230000007953 anoxia Effects 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000031225 myocardial ischemia Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000008899 fufang danshen Substances 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 3
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 3
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010060965 Arterial stenosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- PRYXPGFZVGZNBL-ADLFWFRXSA-N salviol Chemical compound CC(C)c1cc2CC[C@H]3C(C)(C)C[C@H](O)C[C@]3(C)c2cc1O PRYXPGFZVGZNBL-ADLFWFRXSA-N 0.000 description 1
- AJSGWTLZEUBGFV-UHFFFAOYSA-N salviol Natural products CC(C)c1cc2CCC3C(CC(O)CC3(C)C)c2cc1O AJSGWTLZEUBGFV-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
The treatment group | Produce effects 84 (59.2%) | Effective 50 (35.2%) | Invalid 8 (5.6%) | Effective percentage 94.4% |
Matched group | 52(53.1%) | 31(31.6%) | 15(15.3%) | 84.7% |
Typing | The example number | Produce effects | Effectively | Invalid | Effective percentage % |
Blood stasis due to qi deficiency | 78 | 47(60.3%) | 27(34.6%) | 4(5.1%) | 94.9% |
Qi depression to blood stasis | 64 | 37(57.8%) | 23(35.9%) | 4(6.3%) | 93.7% |
Add up to | 142 | 84(59.2%) | 50(35.2%) | 8(5.6%) | 94.4% |
Typing | The example number | Produce effects | Effectively | Invalid | Effective percentage % |
Blood stasis due to qi deficiency | 55 | 2749.1%) | 19(34.5%) | 9(16.4%) | 83.6% |
Qi depression to blood stasis | 43 | 25(58.1%) | 12(27.9%) | 6(14%) | 86% |
Add up to | 98 | 52(53.1%) | 31(31.6%) | 15(15.3%) | 84.7% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100979713A CN1306951C (en) | 2005-09-02 | 2005-09-02 | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100979713A CN1306951C (en) | 2005-09-02 | 2005-09-02 | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1733242A true CN1733242A (en) | 2006-02-15 |
CN1306951C CN1306951C (en) | 2007-03-28 |
Family
ID=36075997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100979713A Active CN1306951C (en) | 2005-09-02 | 2005-09-02 | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1306951C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084995B (en) * | 2006-06-08 | 2011-10-05 | 天津天士力制药股份有限公司 | Medicinal composition containing red sage root and storax, preparation method and preparation |
CN104288505A (en) * | 2014-09-10 | 2015-01-21 | 秦永双 | Traditional Chinese medicine preparation for treating qi deficiency and blood stasis type coronary heart disease and nursing method |
CN106728877A (en) * | 2017-02-15 | 2017-05-31 | 南京市第医院 | It is a kind of to treat medicament of coronary disease and angina pectoris and preparation method thereof |
CN108096433A (en) * | 2017-12-31 | 2018-06-01 | 何江 | Treat Chinese medicinal capsule of Senile Coronary Heart Disease syndrome of blood stasis due to qi deficiency and preparation method thereof |
CN110339326A (en) * | 2019-08-29 | 2019-10-18 | 朱江 | A kind of logical heart ball of stilbene deer |
CN115089628A (en) * | 2022-07-08 | 2022-09-23 | 北京康恩泰生物医药有限公司 | Traditional Chinese medicine granule for treating coronary heart disease |
-
2005
- 2005-09-02 CN CNB2005100979713A patent/CN1306951C/en active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084995B (en) * | 2006-06-08 | 2011-10-05 | 天津天士力制药股份有限公司 | Medicinal composition containing red sage root and storax, preparation method and preparation |
CN104288505A (en) * | 2014-09-10 | 2015-01-21 | 秦永双 | Traditional Chinese medicine preparation for treating qi deficiency and blood stasis type coronary heart disease and nursing method |
CN106728877A (en) * | 2017-02-15 | 2017-05-31 | 南京市第医院 | It is a kind of to treat medicament of coronary disease and angina pectoris and preparation method thereof |
CN108096433A (en) * | 2017-12-31 | 2018-06-01 | 何江 | Treat Chinese medicinal capsule of Senile Coronary Heart Disease syndrome of blood stasis due to qi deficiency and preparation method thereof |
CN110339326A (en) * | 2019-08-29 | 2019-10-18 | 朱江 | A kind of logical heart ball of stilbene deer |
CN115089628A (en) * | 2022-07-08 | 2022-09-23 | 北京康恩泰生物医药有限公司 | Traditional Chinese medicine granule for treating coronary heart disease |
Also Published As
Publication number | Publication date |
---|---|
CN1306951C (en) | 2007-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
CN1857618A (en) | Chinese medicine preparation for reducing sugar | |
CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
CN1628760A (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
CN1306951C (en) | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same | |
CN101822789B (en) | Hypotensor treating essential hypertension | |
CN104873705A (en) | Medicinal composition for treating angina pectoris of coronary heart disease and application thereof | |
CN102048939B (en) | Medicament for treating sinus bradycardia | |
CN102343049B (en) | Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity | |
CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
CN101007159A (en) | Traditional Chinese medicine for preventing and controlling tumor | |
CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
CN102908425A (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
CN105902853A (en) | Traditional Chinese medicine preparation for preparing hypertension | |
CN1391949A (en) | Chinese medicine compound preparation for curing pancreatic cancer | |
CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
CN101057945A (en) | Traditional Chinese medicine for treating digestive cancer and its producing method | |
CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
CN1814163A (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
CN1247237C (en) | Medicinal composition for treating coronary disease and its preparation and application | |
CN112206279B (en) | Traditional Chinese medicine composition for treating ventricular arrhythmia and preparation method and application thereof | |
CN111388623B (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN1853711A (en) | Xinmaikangzhong Chinese medicinal composition and preparation thereof | |
CN105770520A (en) | Medicine preparation used for treating coronary heart disease and application thereof | |
CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same Effective date of registration: 20110705 Granted publication date: 20070328 Pledgee: Anguo branch of China Co truction Bank Corp Pledgor: Baoding Chinese Medicine Preparing Co., Ltd. Registration number: 2011990000254 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20121123 Granted publication date: 20070328 Pledgee: Anguo branch of China Co truction Bank Corp Pledgor: Baoding Chinese Medicine Preparing Co., Ltd. Registration number: 2011990000254 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same Effective date of registration: 20131210 Granted publication date: 20070328 Pledgee: Bank of Hebei, Limited by Share Ltd, Baoding branch Pledgor: Jin Mu|Baoding traditional Chinese Medicine Co., Ltd. Registration number: 2013990000956 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141216 Granted publication date: 20070328 Pledgee: Bank of Hebei, Limited by Share Ltd, Baoding branch Pledgor: Jin Mu| Baoding traditional Chinese Medicine Co., Ltd. Registration number: 2013990000956 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP01 | Change in the name or title of a patent holder |
Address after: Mitutoyo road 071000 Hebei city of Baoding province No. 237 Patentee after: Baoding traditional Chinese medicine and pharmacy Limited by Share Ltd Address before: Mitutoyo road 071000 Hebei city of Baoding province No. 237 Patentee before: Baoding Chinese Medicine Preparing Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |